-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

A Complement Inhibitor for PNH

Sponsor: Apellis Pharmaceuticals
Program: Product Theaters
Sunday, December 10, 2023: 11:30 AM-12:30 PM
Room 5B (San Diego Convention Center)
Peter Hillmen, MD, Apellis Pharmaceuticals and Mary Rowan, RN, BSN, Apellis Pharmaceuticals
No relevant conflicts of interest to declare.
For In-Person Participants Only

This session will include a patient perspective provided by Louis.

See more of: Product Theaters